
Glaukos Prepares for New Product Launches
Glaukos Corp. is in the process of an expanded roll out for what it says is a game-changing device. The product, the iDose TR, is said to be the first long-term sustained release pharmaceutical for the treatment of glaucoma, according to the Aliso Viejo- …